Target intelligence / Profile preview

RNA, U6 small nuclear 1200, pseudogene (RNU6-1200P)

Target
RNU6-1200P
Molecular classification
Non-coding RNA, Pseudogene, Small nuclear RNA pseudogene, Other
01

Overview

RNU6-1200P (RNA, U6 small nuclear 1200, pseudogene) is a pseudogene member of the U6 small nuclear RNA family, classified as a non-coding RNA, with no evidence supporting a direct therapeutic target role or involvement in drug interactions. RNU6-1200P (RNA, U6 small nuclear 1200, pseudogene) is a human pseudogene variant derived from the U6 small nuclear RNA gene family. U6 small nuclear RNAs (snRNAs) are a highly conserved group of non-coding RNAs involved in the catalytic core of the spliceosome, essential for intron removal from pre-mRNA during splicing[1][3]. The human genome contains hundreds of U6 snRNA gene copies and many U6-derived pseudogenes, reflecting the evolutionary importance of the U6 sequence[2][3]. Pseudogenes like RNU6-1200P lack canonical function—they do not produce functional RNA, do not assemble into spliceosomal complexes, and have not been implicated as regulators, biomarkers, or therapeutic targets[5]. Their primary significance is as genomic relics of functionally active U6 genes[3][5]. No drugs, disease roles, or safety considerations are applicable to this transcript.

Other names
RNU6-1200PRNA, U6 small nuclear 1200, pseudogeneU6 pseudogene (generic family term)
02

Mechanism of action

None (not a known drug target)

03

Biological functions

No known function (as this is a pseudogene, not a functional transcript)
04

Disease associations

Other (no evidence links this pseudogene to disease processes)
05

Safety considerations

None
06

Interacting drugs

None reported
07

Biomarkers

None established

Beyond the preview

Go deeper on RNA, U6 small nuclear 1200, pseudogene (RNU6-1200P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1200, pseudogene (RNU6-1200P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call